オートファジーにおけるVPS15によるPI3キナーゼ調節のための構造経路
Annan S I Cook1,2,3, Minghao Chen2,3,4, Thanh N Nguyen3,5,6,7
1Graduate Group in Biophysics, University of California, Berkeley, Berkeley, CA, USA.
まとめ
構造的な洞察は,VPS34の脂質キナーゼ活性化がPI3K複合体内でどのように調節されているかを明らかにします. 凍結EMは,VPS15シドキナーゼ結合とGTPと膜の相互作用が,フォスファチチドリノシトール-3酸塩の産生を活性化するための鍵であることを示しています.
科学分野:
- 分子生物学
- 構造生物学
- 細胞生物学
背景:
- クラスIIIのフォスファディチルイノシトール-3キナーゼ複合体 (PI3KC3-C1とPI3KC3-C2) は,マクロオートファジーや内分泌成熟などの細胞過程において極めて重要です.
- PI3KC3-C1の活性化メカニズム,特にVPS34脂質キナーゼを理解することは,その生物学的機能を解読するために不可欠です.
研究 の 目的:
- PI3KC3-C1酵素活性化の構造経路を解明する.
- 完全なPI3K複合体内でVPS34脂質キナーゼがどのように活性化されるかについての原子学的詳細を提供するために.
主な方法:
- PI3KC3- C1の構造を分析するために,冷凍電子顕微鏡 (cryo- EM) が使用されました.
- 構造分析は酵素複合体の非活性および活性構造に重点を置いた.
主要な成果:
- VPS15偽キナーゼの非活性構造は,そのN-ミリスタートを隔離し,非活性状態を安定させます.
- 酵素の活性化には,N-ミリスタートとVPS34脂質キナーゼの放出が含まれる.
- GTPとVPS15シドキナーゼの結合と膜相互作用は,活性化と自己抑制放出を促進する相互作用を安定させる.
結論:
- この研究は,PI3KC3-C1複合体内のVPS34脂質キナーゼ活性化の構造的基礎を明らかにしています.
- これらの発見は,重要なシグナリングリピドであるフォスファチチドリノシトール-3リン酸の産生を調節する詳細な洞察を提供します.
関連する概念動画
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Phosphoinositides and PIPs
8.3K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.3K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Autophagy
4.1K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.1K
Delivery Pathways to the Lysosome
6.1K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


